Sign in Subscribe

Healthcare & Pharmaceutical

Pharmaceuticals, Hospitals & healthcare providers, Biotech & life sciences, Diagnostics, Health-tech & digital health, Medical devices & equipment, Health policy & the healthcare (clinical and diagnostics segment) economy

Surat's SMT begins European trial pitting its heart occluder against Abbott's Amplatzer

Surat's SMT begins European trial pitting its heart occluder against Abbott's Amplatzer

The Surat device maker has enrolled its first patient in a 1,260-patient European trial comparing its Cocoon occluder against Abbott's Amplatzer family, across about 60 centres.

What US drug tariffs mean for Indian pharma

What US drug tariffs mean for Indian pharma

America is using tariffs to pull drug manufacturing back home, a direct threat to the cheap generics India supplies to the world. Seen through Natco Pharma, what the 2028 tariff clock means for Indian drugmakers, and why it could end up leaving patients paying more.

Amplifon quits India

Amplifon quits India

The world's largest hearing care retailer has left India. Its own disclosure shows the business it sold to Hearzap turned over about €12 million and dragged on group profits. Neither side disclosed the price.

Pharma leaders flag API import dependence and thin R&D spend at CPHI build-up

Pharma leaders flag API import dependence and thin R&D spend at CPHI build-up

The Hyderabad briefing ahead of CPHI & PMEC India 2026 talked about the industry's dependence on external inputs, the need for deeper investment in R&D and the growing pressure to meet evolving compliance standards, besides logistics of the events.

CPHI & PMEC India splits across two venues in November 2026

CPHI & PMEC India splits across two venues in November 2026

CPHI and PMEC, India’s largest pharma exhibitions will run across Delhi and Greater Noida in November because registrations outgrew any single venue.

Syngene swings to a quarterly loss as a big client pulls back

Syngene swings to a quarterly loss as a big client pulls back

Syngene International slipped to a rare quarterly net loss in the June quarter after a major biologics client cut back, shares fell nearly 9%

Natco Pharma Limited

Natco Pharma Limited

A first look at our conversation with Rajeev Nannapaneni, Vice Chairman and CEO of Natco Pharma, on strategy and the way ahead for the Hyderabad complex-generics and oncology major. Full story to follow.